Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 66.33-5.7996.48-31.65-4.68

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is 66.33 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202466.33
Mar2023-5.79
Mar202296.48
Mar2021-31.65
Mar2020-4.68

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 66.33
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65
Negative
Mar2020 -4.68 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹142.4 Cr -2.2% -9.5% -32.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹180,488.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,452.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,057.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,220.0 Cr -4.1% -3.8% -4.3% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-2.2%

-9.5%

-32.1%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses